Biosimilars Market Size, Trends, and Strategic Insights 2025-2032 The biosimilars market is witnessing accelerated market growth driven by rising demand for cost-effective biological therapies and patent expirations of blockbuster biologics. Market players are focusing on innovative market growth strategies to capitalize on expanding market opportunities propelled by regulatory facilitations and increasing healthcare expenditure. Market Size and Overview The global biosimilars market size is estimated to be valued at USD 42.53 billion in 2025 and is expected to reach USD 133.5 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18% from 2025 to 2032. Biosimilars Market Size is supported by increasing approvals of biosimilar products and widening adoption in treatment fields such as oncology and autoimmune diseases. Market revenue is also driven by enhanced healthcare infrastructure and favorable reimbursement policies in key regions. Biosimilars Market-https://www.coherentmarketinsights.com/market-insight/biosimilars-market-750